CCXI Chemocentryx Inc

ChemoCentryx Inc is a biopharmaceutical company. It is engaged in discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer.

$36.28  -2.60 (-6.69%)
As of 11/26/2021 13:00:01 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/08/2012
Outstanding shares:  69,900,000
Average volume:  1,439,474
Market cap:   $2,717,712,000
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    16383L106
ISIN:        US16383L1061
Sedol:      B6ZL968
Valuation   (See tab for details)
PE ratio:   -20.94
PB ratio:   8.03
PS ratio:   80.00
Return on equity:   -38.34%
Net income %:   -356.49%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy